European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Instituto de Biologia Experimental e Tecnológica (Ibet), Oeiras, Portugal

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Instituto de Biologia Experimental e Tecnológica (Ibet)

Identification

Pas
PT 502112255
Lei
254900XMYUN5L8J5E735
EUID
PTIRNMJ.502112255

Address

Quinta do Marquês, 2780-155 Oeiras, Portugal

Corporate purpose

72.10.1
Research and experimental development on biotechnology

History

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Premium
Premium
5Member of the board
3Vice president
5Auditor
2Auditor
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more

Learn more View plans

Publications

14 Jul 2025
Segment clas­si­fi­ca­tion
15 May 2025 in Hor
EU funding (€200,188): Multiplying feasible microalgae-derived products at scale
4 Jul 2024 via Ages - Osterreichische Agentur FUR Gesundheit UND Ernahrungssicherheit GmbH
EU funding (€486,806): Characterization and Recovery of Bionanoparticles for Vaccine Delivery and Gene Therapy
1 Jul 2024
Member of the board: A. Mota Rodrigues · Vice president: Joerg Holenz, M. Teixeira Carrondo · Companies
17 May 2024 as Instituto de Biologia Experimental Tecnológica
Wikidata entry
21 Sept 2023
Patent: Protease Condition-Directed Nucleic Acid Recombination, Methods and Uses of which
24 Jul 2023 via AstraZeneca AB
EU funding (€243,403): Organoid technologies for disease modeling, drug discovery and development for rare diseases
21 Apr 2023
Publicações de Atos Societários e de outras entidades
1 Apr 2023 in Hor
EU funding (€1,000,000): Next generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-cell acute lymphoblastic leukemia
7 Nov 2022
Dismissed: J. Ferreira Machado
1 Feb 2022 in Hor
EU funding (€12,111.02): Integrated Services for Infectious Disease Outbreak Research
24 May 2021
Member of the board: A. Mota Rodrigues · Vice president (2) · Companies
3 Dec 2020
Wordmark: “Science4Food“
Year 2020 in Hor
7 EU fundings (€2,785,827): Accelerating Research & Development for Advanced Therapies …
24 Jun 2020
Dismissed: Rita Oliveira
24 Jun 2020
Publicações de Atos Societários e de outras entidades
24 Jun 2020
Publicações de Atos Societários e de outras entidades
20 May 2020
Patent: Modified envelope glycoproteins for Retroviridae virus vector pseudotyping and methods for the preparation thereof
18 May 2020
Publicações de Atos Societários e de outras entidades
14 Oct 2019 in Hor
EU funding (€412,250): Bio Innovation of a Circular Economy for Plastics
1 Jun 2019 in Hor
EU funding (€352,357): Vaccine for prevention and treatment of Trypanosoma cruzi infection
14 Feb 2019 in Hor
EU funding (€296,325): Zooming the link between diet and brain health: how phenolic metabolites modulate brain inflammation
Year 2018 in Hor
5 EU fundings (€1,872,918): European Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process development through single cell analysis …
18 May 2018
Member of the board: J. de Brito Ribeiro · Vice president (3) · Auditor (4)
28 Aug 2017 via Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
EU funding (€238,356): Integrated Training in Dry Eye Disease Drug Development (IT-DED3)
1 May 2017 in Hor
EU funding (€916,708): European Vaccine Research and Development Infrastructure
Year 2016 in Hor
4 EU fundings (€984,478): Innovative approaches to turn agricultural waste into ecological and economic assets …
27 Aug 2015 in Hor
EU funding (€100,000): ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences.
11 Aug 2015 as Instituto de Biologia Experimental e Tecnologica
EU funding: Exploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therapeutics
15 May 2015
Vice president: L. de Mesquita Dias, M. Teixeira Carrondo · Member of the board (5) · Auditor (4)
1 Mar 2015 in Hor
EU funding (€1,663,706): Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes
27 Feb 2014
Publicações de Atos Societários e de outras entidades
23 Aug 2013
Publicações de Atos Societários e de outras entidades
22 Aug 2013
Publicações de Atos Societários e de outras entidades
1 Aug 2013
Publicações de Atos Societários e de outras entidades
27 Apr 2012
Persons · Address
2 Oct 2011
Word figurative mark: “IBET INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA“
9 Feb 2011
Auditor: Laboratórios Bial · Auditor (3 companies)
9 Feb 2011
Member of the board: T. da Silva Alves
11 Feb 2009 as Ibet-Instituto de Biologia Experimental e Tecnológica
Word figurative mark: “iBET“
12 Jun 2007 via Eic - Empresa Internacional de Certificação SA
Member of the board: Eic - Empresa Internacional de Certificação SA
17 Apr 2006
Publicações de Atos Societários e de outras entidades
18 Jan 2006 as Instituto de Biologia Experimental e Tecnologia (Ibet)
Patent: Mannosyl(1-2)Glycosyl(1-2)Glycerat zur Stabilisierung und Konservierung von Biomaterialien
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.